(2020). Leaving no stone unturned: Allosteric targeting of SARS-CoV-2 Spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor binding domain.
Chicago Style (17th ed.) CitationLeaving No Stone Unturned: Allosteric Targeting of SARS-CoV-2 Spike Protein at Putative Druggable Sites Disrupts Human Angiotensin-converting Enzyme Interactions at the Receptor Binding Domain. 2020.
MLA (8th ed.) CitationLeaving No Stone Unturned: Allosteric Targeting of SARS-CoV-2 Spike Protein at Putative Druggable Sites Disrupts Human Angiotensin-converting Enzyme Interactions at the Receptor Binding Domain. 2020.
Warning: These citations may not always be 100% accurate.